199 related articles for article (PubMed ID: 35800450)
21. [Acupuncture improves hepatic lipid metabolism by suppressing oxidative stress in obese nonalcoholic fatty liver disease rats].
Wang HY; Liang CM; Cui JW; Pan L; Hu H; Fang HJ
Zhen Ci Yan Jiu; 2019 Mar; 44(3):189-94. PubMed ID: 30945501
[TBL] [Abstract][Full Text] [Related]
22. The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules.
Dang Y; Hao S; Zhou W; Zhang L; Ji G
BMC Complement Altern Med; 2019 Jan; 19(1):8. PubMed ID: 30616587
[TBL] [Abstract][Full Text] [Related]
23. [Mechanism of geniposide in improving free fatty acid metabolism in rats with non-alcoholic fatty liver disease].
Liang HQ; Lin MT; Zhao X; Zhou HH; Wang HG; Li GH; Wang YJ; Zhang LM; Wang YY; Chen SD
Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(3):470-475. PubMed ID: 28868866
[TBL] [Abstract][Full Text] [Related]
24. Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro.
Hwangbo H; Kim MY; Ji SY; Kim SY; Lee H; Kim GY; Park C; Keum YS; Hong SH; Cheong J; Choi YH
Antioxidants (Basel); 2020 Oct; 9(11):. PubMed ID: 33114221
[TBL] [Abstract][Full Text] [Related]
25. Astragaloside IV Improves High-Fat Diet-Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway.
Liu YL; Zhang QZ; Wang YR; Fu LN; Han JS; Zhang J; Wang BM
Front Pharmacol; 2020; 11():605064. PubMed ID: 33708118
[No Abstract] [Full Text] [Related]
26. Berberine attenuates hepatic oxidative stress in rats with non-alcoholic fatty liver disease via the Nrf2/ARE signalling pathway.
Deng Y; Tang K; Chen R; Nie H; Liang S; Zhang J; Zhang Y; Yang Q
Exp Ther Med; 2019 Mar; 17(3):2091-2098. PubMed ID: 30867696
[TBL] [Abstract][Full Text] [Related]
27. [Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].
Zhong FW; Li GX; Zeng L
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2500-2508. PubMed ID: 35531697
[TBL] [Abstract][Full Text] [Related]
28. Kuijieling decoction suppresses NLRP3-Mediated pyroptosis to alleviate inflammation and experimental colitis in vivo and in vitro.
Jie F; Xiao S; Qiao Y; You Y; Feng Y; Long Y; Li S; Wu Y; Li Y; Du Q
J Ethnopharmacol; 2021 Jan; 264():113243. PubMed ID: 32781258
[TBL] [Abstract][Full Text] [Related]
29. ZeXie decoction alleviates non-alcoholic fatty liver disease in rats: the study of genes, lipids, and gut microbiotas.
Zhang F; Wu J; Ruan H; Xia J; Xue H; Wang J; Li Q; Shi Y
Biochem Biophys Res Commun; 2022 Dec; 632():129-138. PubMed ID: 36209581
[TBL] [Abstract][Full Text] [Related]
30. [Effects of GPR81 agonist on insulin resistance in rats with nonalcoholic fatty liver disease].
Zhang Y; Lu QH; Cao HF; Zhang SR; Wang H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Jul; 37(4):354-358. PubMed ID: 34374253
[No Abstract] [Full Text] [Related]
31. Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease.
Jiang G; Chen D; Li W; Liu C; Liu J; Guo Y
Pharm Biol; 2020 Dec; 58(1):1177-1183. PubMed ID: 33253604
[TBL] [Abstract][Full Text] [Related]
32. [Mechanism of Huanglian Wendan Decoction in improving impaired glucose tolerance based on skeletal muscle NLRP3/caspase-1/IL-1β, IL-18 pathway].
Dong WR; Li H; Li YF; Wang N; Ma BY; Lu GL; Xin XR; Chen BB
Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4480-4487. PubMed ID: 34581053
[TBL] [Abstract][Full Text] [Related]
33. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
Shen SH; Zhong TY; Peng C; Fang J; Lv B
BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
[TBL] [Abstract][Full Text] [Related]
34. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice].
Tian X; Xiong Q; Chen L; Wen JR; Ru Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123
[No Abstract] [Full Text] [Related]
35. Curcumin mitigates aflatoxin B1-induced liver injury via regulating the NLRP3 inflammasome and Nrf2 signaling pathway.
Wang Y; Liu F; Liu M; Zhou X; Wang M; Cao K; Jin S; Shan A; Feng X
Food Chem Toxicol; 2022 Mar; 161():112823. PubMed ID: 35063475
[TBL] [Abstract][Full Text] [Related]
36. Exploring the Protective Effects and Mechanism of Crocetin From Saffron Against NAFLD by Network Pharmacology and Experimental Validation.
Xu Z; Lin S; Gong J; Feng P; Cao Y; Li Q; Jiang Y; You Y; Tong Y; Wang P
Front Med (Lausanne); 2021; 8():681391. PubMed ID: 34179049
[No Abstract] [Full Text] [Related]
37. Yinchen Linggui Zhugan decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease by modulation of SIRT1/Nrf2 signaling pathway and gut microbiota.
Jiang H; Mao T; Sun Z; Shi L; Han X; Zhang Y; Zhang X; Wang J; Hu J; Zhang L; Li J; Han H
Front Microbiol; 2022; 13():1001778. PubMed ID: 36578580
[TBL] [Abstract][Full Text] [Related]
38. Multi-Omics Integration Analysis Identifies Lipid Disorder of a Non-Alcoholic Fatty Liver Disease (NAFLD) Mouse Model Improved by Zexie-Baizhu Decoction.
Cao Y; Shi J; Song L; Xu J; Lu H; Sun J; Hou J; Chen J; Wu W; Gong L
Front Pharmacol; 2022; 13():858795. PubMed ID: 35795562
[TBL] [Abstract][Full Text] [Related]
39. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
Chen M; Xing J; Pan D; Peng X; Gao P
Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
[TBL] [Abstract][Full Text] [Related]
40. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway.
Shen S; Wang K; Zhi Y; Shen W; Huang L
Cell Cycle; 2020 Nov; 19(22):3042-3053. PubMed ID: 33121337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
